Muscle, wasting/atrophy NOS: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
* Any cause, including deconditioning, disuse (e.g. due to prolonged bedrest, or after a stroke), [[Malnutrition]], etc | * Any cause, including deconditioning, disuse (e.g. due to prolonged bedrest, or after a stroke), [[Malnutrition]], etc | ||
* Sarcopenia-age related progressive loss of muscle mass and strength | * Sarcopenia-age related progressive loss of muscle mass and strength | ||
* To code muscle weakness due to an active Covid infection use codes: [[Muscle, wasting/atrophy NOS]], with [[COVID-19 (SARS-COV-2)]], and [[Carrier of infectious disease, unspecified]] | * To code muscle weakness due to an active Covid infection, where this is the only evidence of the infection, use codes: [[Muscle, wasting/atrophy NOS]], with [[COVID-19 (SARS-COV-2)]], and [[Carrier of infectious disease, unspecified]] | ||
{{ICD10 Acquired neuromuscular weakness}} | {{ICD10 Acquired neuromuscular weakness}} | ||